| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.783 | 0.004 | 0.783 | Spasmolytic | 0.719 0.005 DBMET01516 0.589 0.014 DBMET01519 0.504 0.022 DBMET01520 | ||
| 0.649 | 0.003 | 0.649 | 5 Hydroxytryptamine 1F antagonist | 0.585 0.004 DBMET01516 0.577 0.004 DBMET01519 0.409 0.005 DBMET01520 | ||
| 0.643 | 0.005 | 0.778 | Anticonvulsant | 0.579 0.008 DBMET01516 0.778 0.004 DBMET01519 0.729 0.005 DBMET01520 | DBMET01519 | |
| 0.551 | 0.004 | 0.694 | Histamine H1 receptor antagonist | 0.401 0.004 DBMET01516 0.694 0.003 DBMET01519 0.527 0.004 DBMET01520 | DBMET01519 | |
| 0.497 | 0.033 | 0.497 | Aldehyde oxidase inhibitor | 0.426 0.043 DBMET01519 | ||
| 0.439 | 0.017 | 0.464 | Psychostimulant | 0.464 0.014 DBMET01516 0.412 0.021 DBMET01519 0.437 0.017 DBMET01520 | DBMET01516 | |
| 0.433 | 0.015 | 0.433 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.35 0.036 DBMET01516 0.345 0.038 DBMET01519 0.271 0.087 DBMET01520 | ||
| 0.435 | 0.023 | 0.435 | Cardiotonic | 0.341 0.042 DBMET01516 0.35 0.039 DBMET01519 0.266 0.072 DBMET01520 | ||
| 0.417 | 0.005 | 0.502 | Antihistaminic | 0.332 0.009 DBMET01516 0.502 0.005 DBMET01519 0.409 0.005 DBMET01520 | DBMET01519 | |
| 0.412 | 0.005 | 0.412 | 5 Hydroxytryptamine 7 antagonist | 0.271 0.007 DBMET01516 0.202 0.012 DBMET01519 0.112 0.023 DBMET01520 | ||
| 0.408 | 0.005 | 0.472 | Histamine antagonist | 0.323 0.009 DBMET01516 0.472 0.005 DBMET01519 0.379 0.006 DBMET01520 | DBMET01519 | |
| 0.391 | 0.005 | 0.392 | Alpha 2b adrenoreceptor antagonist | 0.392 0.005 DBMET01516 0.156 0.036 DBMET01519 0.157 0.036 DBMET01520 | DBMET01516 | |
| 0.433 | 0.071 | 0.559 | Analgesic | 0.559 0.035 DBMET01516 0.419 0.076 DBMET01519 0.541 0.039 DBMET01520 | DBMET01516 | |
| 0.358 | 0.006 | 0.358 | Calcium channel blocker | 0.272 0.013 DBMET01516 0.3 0.01 DBMET01519 0.225 0.022 DBMET01520 | ||
| 0.352 | 0.004 | 0.352 | ATPase inhibitor | 0.34 0.004 DBMET01516 0.23 0.02 DBMET01519 0.221 0.024 DBMET01520 | ||
| 0.344 | 0.005 | 0.344 | Mediator release inhibitor | 0.279 0.008 DBMET01516 0.156 0.026 DBMET01519 0.135 0.036 DBMET01520 | ||
| 0.379 | 0.055 | 0.404 | Antithrombotic | 0.404 0.048 DBMET01516 0.29 0.095 DBMET01519 0.307 0.083 DBMET01520 | DBMET01516 | |
| 0.397 | 0.077 | 0.397 | Histamine release inhibitor | 0.285 0.132 DBMET01516 0.31 0.118 DBMET01519 0.211 0.19 DBMET01520 | ||
| 0.315 | 0.004 | 0.315 | Calcium channel L-type blocker | 0.235 0.005 DBMET01516 0.241 0.004 DBMET01519 0.181 0.007 DBMET01520 | ||
| 0.43 | 0.121 | 0.43 | Antiinflammatory | 0.424 0.125 DBMET01516 0.307 0.209 DBMET01519 0.308 0.208 DBMET01520 | ||
| 0.313 | 0.005 | 0.417 | 5 Hydroxytryptamine uptake inhibitor | 0.417 0.005 DBMET01516 0.136 0.018 DBMET01519 0.241 0.009 DBMET01520 | DBMET01516 | |
| 0.324 | 0.017 | 0.336 | 5 Hydroxytryptamine 1E antagonist | 0.336 0.013 DBMET01516 0.188 0.145 DBMET01519 0.208 0.121 DBMET01520 | DBMET01516 | |
| 0.333 | 0.027 | 0.333 | Anesthetic general | 0.24 0.055 DBMET01516 0.189 0.08 DBMET01519 | ||
| 0.308 | 0.013 | 0.308 | Acetylcholine M1 receptor antagonist | 0.257 0.023 DBMET01516 0.197 0.044 DBMET01519 0.153 0.071 DBMET01520 | ||
| 0.298 | 0.005 | 0.298 | Alcohol dehydrogenase inhibitor | 0.243 0.008 DBMET01516 0.191 0.013 DBMET01519 0.147 0.021 DBMET01520 | ||
| 0.296 | 0.009 | 0.296 | Acetylcholine muscarinic antagonist | 0.228 0.018 DBMET01516 0.182 0.029 DBMET01519 0.139 0.051 DBMET01520 | ||
| 0.3 | 0.014 | 0.3 | Cholinergic antagonist | 0.246 0.022 DBMET01516 0.163 0.046 DBMET01519 0.131 0.064 DBMET01520 | ||
| 0.288 | 0.009 | 0.288 | Alpha 2 adrenoreceptor antagonist | 0.278 0.009 DBMET01516 0.086 0.059 DBMET01519 0.083 0.062 DBMET01520 | ||
| 0.294 | 0.015 | 0.294 | 5 Hydroxytryptamine 2B antagonist | 0.207 0.025 DBMET01516 0.109 0.073 DBMET01519 | ||
| 0.278 | 0.016 | 0.278 | Acetylcholine antagonist | 0.229 0.024 DBMET01516 0.15 0.05 DBMET01519 0.12 0.07 DBMET01520 | ||
| 0.29 | 0.031 | 0.29 | P-glycoprotein inhibitor | 0.252 0.041 DBMET01516 0.223 0.052 DBMET01519 0.198 0.065 DBMET01520 | ||
| 0.262 | 0.009 | 0.262 | Alpha 2c adrenoreceptor antagonist | 0.257 0.009 DBMET01516 0.104 0.063 DBMET01519 0.101 0.065 DBMET01520 | ||
| 0.247 | 0.004 | 0.247 | 5 Hydroxytryptamine 5A antagonist | 0.179 0.005 DBMET01516 0.079 0.024 DBMET01519 0.063 0.04 DBMET01520 | ||
| 0.246 | 0.005 | 0.388 | Adrenaline uptake inhibitor | 0.388 0.004 DBMET01516 0.144 0.01 DBMET01519 0.262 0.005 DBMET01520 | DBMET01516 | |
| 0.241 | 0.011 | 0.241 | Calcium channel (voltage-sensitive) blocker | 0.188 0.02 DBMET01516 0.186 0.02 DBMET01519 0.146 0.036 DBMET01520 | ||
| 0.243 | 0.015 | 0.243 | Nav1.3 sodium channel blocker | 0.239 0.016 DBMET01516 0.167 0.038 DBMET01519 0.164 0.039 DBMET01520 | ||
| 0.24 | 0.013 | 0.24 | 5 Hydroxytryptamine 2C antagonist | 0.208 0.016 DBMET01516 | ||
| 0.25 | 0.025 | 0.25 | 5 Hydroxytryptamine antagonist | 0.202 0.033 DBMET01516 | ||
| 0.235 | 0.01 | 0.235 | Calcium antagonist | 0.115 0.038 DBMET01516 0.075 0.068 DBMET01519 | ||
| 0.228 | 0.005 | 0.228 | Sphingomyelinase inhibitor | 0.212 0.008 DBMET01516 0.167 0.018 DBMET01519 0.151 0.024 DBMET01520 | ||
| 0.224 | 0.004 | 0.224 | 5 Hydroxytryptamine 5 antagonist | 0.173 0.006 DBMET01516 0.067 0.028 DBMET01519 0.056 0.043 DBMET01520 | ||
| 0.228 | 0.011 | 0.228 | Alpha 2a adrenoreceptor antagonist | 0.221 0.011 DBMET01516 | ||
| 0.236 | 0.023 | 0.238 | 5 Hydroxytryptamine 3E antagonist | 0.238 0.022 DBMET01516 0.22 0.036 DBMET01519 0.222 0.035 DBMET01520 | DBMET01516 | |
| 0.23 | 0.024 | 0.23 | 5 Hydroxytryptamine 2 antagonist | 0.206 0.029 DBMET01516 | ||
| 0.295 | 0.091 | 0.295 | Vasodilator, coronary | 0.263 0.122 DBMET01516 | ||
| 0.219 | 0.015 | 0.219 | Nav1.4 sodium channel blocker | 0.215 0.016 DBMET01516 0.197 0.02 DBMET01519 0.194 0.02 DBMET01520 | ||
| 0.193 | 0.002 | 0.193 | DNA helicase inhibitor | 0.185 0.002 DBMET01516 0.102 0.005 DBMET01519 0.102 0.005 DBMET01520 | ||
| 0.189 | 0.008 | 0.189 | 5 Hydroxytryptamine 1D antagonist | 0.138 0.014 DBMET01516 0.067 0.041 DBMET01519 | ||
| 0.196 | 0.02 | 0.196 | 5 Hydroxytryptamine 2A antagonist | 0.159 0.026 DBMET01516 | ||
| 0.204 | 0.031 | 0.204 | Anesthetic local | 0.146 0.05 DBMET01516 0.121 0.066 DBMET01519 | ||
| 0.189 | 0.029 | 0.189 | Alpha adrenoreceptor antagonist | 0.179 0.031 DBMET01516 | ||
| 0.195 | 0.036 | 0.195 | Nav1.2 sodium channel blocker | 0.185 0.04 DBMET01516 0.125 0.078 DBMET01519 0.118 0.085 DBMET01520 | ||
| 0.266 | 0.116 | 0.299 | Transcription factor NF kappa B inhibitor | 0.299 0.094 DBMET01516 0.201 0.168 DBMET01520 | DBMET01516 | |
| 0.266 | 0.116 | 0.266 | Vasodilator, peripheral | 0.193 0.184 DBMET01516 0.23 0.144 DBMET01519 | ||
| 0.221 | 0.073 | 0.221 | Antimitotic | 0.153 0.119 DBMET01516 | ||
| 0.16 | 0.012 | 0.16 | 5 Hydroxytryptamine 1B antagonist | 0.116 0.018 DBMET01516 | ||
| 0.156 | 0.009 | 0.156 | Acetylcholine M4 receptor antagonist | 0.102 0.027 DBMET01516 0.095 0.032 DBMET01519 | ||
| 0.205 | 0.067 | 0.205 | Non-steroidal antiinflammatory agent | 0.204 0.068 DBMET01516 | ||
| 0.158 | 0.023 | 0.158 | Gastric antisecretory | 0.156 0.024 DBMET01516 0.136 0.033 DBMET01519 0.134 0.035 DBMET01520 | ||
| 0.145 | 0.016 | 0.145 | Dopamine D1 antagonist | 0.102 0.024 DBMET01516 | ||
| 0.21 | 0.087 | 0.299 | Peptidyltransferase inhibitor | 0.299 0.025 DBMET01516 0.178 0.132 DBMET01519 0.275 0.036 DBMET01520 | DBMET01516 | |
| 0.157 | 0.034 | 0.163 | Antiadrenergic | 0.163 0.032 DBMET01516 | DBMET01516 | |
| 0.136 | 0.014 | 0.161 | Histamine H2 receptor antagonist | 0.161 0.008 DBMET01516 0.096 0.039 DBMET01519 0.115 0.023 DBMET01520 | DBMET01516 | |
| 0.147 | 0.024 | 0.147 | Estrogen antagonist | 0.13 0.038 DBMET01516 0.104 0.088 DBMET01519 | ||
| 0.139 | 0.026 | 0.139 | 5 Hydroxytryptamine 1 antagonist | 0.102 0.036 DBMET01516 | ||
| 0.123 | 0.012 | 0.123 | Acetylcholine M5 receptor antagonist | 0.086 0.022 DBMET01516 0.058 0.045 DBMET01519 | ||
| 0.141 | 0.032 | 0.141 | Ca(v)2.2 blocker | 0.105 0.045 DBMET01516 | ||
| 0.136 | 0.029 | 0.189 | Nitric-oxide synthase inhibitor | 0.189 0.011 DBMET01516 0.087 0.084 DBMET01520 | DBMET01516 | |
| 0.142 | 0.037 | 0.147 | Adrenaline antagonist | 0.147 0.035 DBMET01516 | DBMET01516 | |
| 0.127 | 0.025 | 0.127 | Estrogen receptor beta antagonist | 0.116 0.037 DBMET01516 | ||
| 0.12 | 0.019 | 0.127 | Alpha 1d adrenoreceptor antagonist | 0.127 0.018 DBMET01516 | DBMET01516 | |
| 0.112 | 0.012 | 0.112 | 5 Hydroxytryptamine 6 antagonist | 0.088 0.019 DBMET01516 0.069 0.03 DBMET01519 0.051 0.048 DBMET01520 | ||
| 0.124 | 0.025 | 0.135 | CYP2A6 inhibitor | 0.135 0.021 DBMET01516 0.071 0.057 DBMET01520 | DBMET01516 | |
| 0.153 | 0.058 | 0.167 | Adenylate cyclase stimulant | 0.167 0.038 DBMET01516 0.133 0.095 DBMET01520 | DBMET01516 | |
| 0.142 | 0.05 | 0.142 | Adenylate cyclase inhibitor | 0.117 0.07 DBMET01516 | ||
| 0.183 | 0.095 | 0.235 | Platelet aggregation inhibitor | 0.147 0.132 DBMET01516 0.235 0.059 DBMET01519 0.197 0.083 DBMET01520 | DBMET01519 | |
| 0.117 | 0.032 | 0.117 | Histamine N-methyltransferase inhibitor | 0.081 0.066 DBMET01519 | ||
| 0.11 | 0.029 | 0.11 | 5 Hydroxytryptamine 1A antagonist | 0.078 0.041 DBMET01516 | ||
| 0.115 | 0.034 | 0.117 | Thioredoxin inhibitor | 0.117 0.032 DBMET01516 | DBMET01516 | |
| 0.117 | 0.038 | 0.117 | Alpha 1 adrenoreceptor antagonist | 0.11 0.04 DBMET01516 | ||
| 0.098 | 0.019 | 0.098 | Dopamine uptake inhibitor | 0.09 0.021 DBMET01516 0.058 0.04 DBMET01519 0.054 0.044 DBMET01520 | ||
| 0.198 | 0.122 | 0.198 | Immunostimulant | 0.169 0.14 DBMET01516 | ||
| 0.107 | 0.033 | 0.121 | Alpha 1b adrenoreceptor antagonist | 0.121 0.029 DBMET01516 | DBMET01516 | |
| 0.106 | 0.035 | 0.119 | Glutamate release inhibitor | 0.119 0.023 DBMET01516 | DBMET01516 | |
| 0.093 | 0.024 | 0.099 | Beta tubulin antagonist | 0.099 0.023 DBMET01516 0.083 0.028 DBMET01519 0.088 0.026 DBMET01520 | DBMET01516 | |
| 0.123 | 0.056 | 0.123 | DNA intercalator | |||
| 0.075 | 0.008 | 0.075 | 5 Hydroxytryptamine 3B antagonist | 0.049 0.015 DBMET01516 | ||
| 0.094 | 0.031 | 0.094 | Estrogen receptor alpha antagonist | |||
| 0.067 | 0.013 | 0.067 | Kinesin-like protein 1 inhibitor | |||
| 0.067 | 0.013 | 0.067 | Kinesin antagonist | |||
| 0.082 | 0.028 | 0.082 | Acetylcholine M2 receptor antagonist | 0.055 0.049 DBMET01516 0.056 0.049 DBMET01519 | ||
| 0.062 | 0.009 | 0.062 | DNA gyrase subunit A inhibitor | 0.059 0.01 DBMET01516 | ||
| 0.083 | 0.031 | 0.083 | Dopamine D3 antagonist | 0.065 0.041 DBMET01516 0.062 0.043 DBMET01519 | ||
| 0.092 | 0.042 | 0.092 | Dopamine antagonist | 0.069 0.055 DBMET01516 | ||
| 0.069 | 0.021 | 0.069 | Bcl-xL inhibitor | 0.062 0.035 DBMET01519 | ||
| 0.113 | 0.064 | 0.129 | Nav1.5 sodium channel blocker | 0.129 0.044 DBMET01516 | DBMET01516 | |
| 0.113 | 0.067 | 0.113 | Photosensitizer | |||
| 0.064 | 0.022 | 0.084 | Thromboxane synthase inhibitor | 0.079 0.012 DBMET01516 0.069 0.019 DBMET01519 0.084 0.01 DBMET01520 | DBMET01520 | |
| 0.126 | 0.086 | 0.165 | Neurotrophic factor | 0.165 0.047 DBMET01519 0.125 0.087 DBMET01520 | DBMET01519 | |
| 0.078 | 0.04 | 0.078 | Dopamine D2 antagonist | |||
| 0.066 | 0.03 | 0.066 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.042 | 0.009 | 0.042 | Urotensin II agonist | 0.033 0.013 DBMET01519 | ||
| 0.054 | 0.021 | 0.054 | Opioid kappa receptor agonist | 0.043 0.03 DBMET01516 0.047 0.026 DBMET01519 0.038 0.036 DBMET01520 | ||
| 0.157 | 0.124 | 0.157 | HERG channel blocker | |||
| 0.071 | 0.037 | 0.092 | Beta adrenoreceptor antagonist | 0.092 0.02 DBMET01516 | DBMET01516 | |
| 0.055 | 0.022 | 0.055 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.195 | 0.169 | 0.195 | Cholesterol antagonist | |||
| 0.06 | 0.038 | 0.06 | Ryanodine receptor antagonist | |||
| 0.052 | 0.031 | 0.052 | Squalene epoxidase inhibitor | |||
| 0.053 | 0.033 | 0.053 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.038 DBMET01516 | ||
| 0.156 | 0.141 | 0.156 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.052 | 0.04 | 0.052 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.066 | 0.053 | 0.066 | Alpha 1a adrenoreceptor antagonist | 0.066 0.054 DBMET01516 | ||
| 0.062 | 0.05 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.042 DBMET01516 | DBMET01516 | |
| 0.153 | 0.142 | 0.197 | Platelet antagonist | 0.157 0.137 DBMET01516 0.195 0.105 DBMET01519 0.197 0.103 DBMET01520 | DBMET01520 | |
| 0.075 | 0.064 | 0.075 | Carbonic anhydrase VI inhibitor | |||
| 0.056 | 0.046 | 0.056 | Acetylcholine M3 receptor antagonist | |||
| 0.055 | 0.045 | 0.055 | Dopamine D4 antagonist | |||
| 0.065 | 0.055 | 0.065 | Exportin-1 inhibitor | |||
| 0.091 | 0.081 | 0.091 | Carbonic anhydrase XV inhibitor | |||
| 0.051 | 0.044 | 0.051 | Carbonic anhydrase VB inhibitor | |||
| 0.085 | 0.08 | 0.438 | Chemokine receptor antagonist | 0.438 0.005 DBMET01519 0.388 0.005 DBMET01520 | DBMET01519 | |
| 0.035 | 0.03 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.009 | 0.005 | 0.009 | Free fatty acid receptor 2 antagonist | |||
| 0.038 | 0.034 | 0.04 | Oxytocin agonist | 0.04 0.032 DBMET01516 | DBMET01516 | |
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.041 | 0.042 | 0.063 | Dopamine transporter inhibitor | 0.063 0.023 DBMET01516 0.042 0.041 DBMET01520 | DBMET01516 | |
| 0.055 | 0.056 | 0.092 | NMDA receptor agonist | 0.092 0.022 DBMET01516 | DBMET01516 | |
| 0.03 | 0.037 | 0.039 | Opioid delta receptor agonist | 0.039 0.02 DBMET01519 0.037 0.023 DBMET01520 | DBMET01519 | |
| 0.064 | 0.072 | 0.074 | Analgesic, opioid | 0.074 0.056 DBMET01519 0.067 0.066 DBMET01520 | DBMET01519 | |
| 0.062 | 0.075 | 0.429 | CC chemokine receptor antagonist | 0.429 0.004 DBMET01519 0.394 0.005 DBMET01520 | DBMET01519 | |
| 0.039 | 0.053 | 0.058 | Beta 2 adrenoreceptor antagonist | 0.058 0.027 DBMET01516 | DBMET01516 | |
| 0.043 | 0.059 | 0.065 | Beta 1 adrenoreceptor antagonist | 0.065 0.031 DBMET01516 | DBMET01516 | |
| 0.038 | 0.056 | 0.056 | Thromboxane antagonist | 0.05 0.042 DBMET01519 0.056 0.035 DBMET01520 | DBMET01520 | |
| 0.015 | 0.034 | 0.029 | CC chemokine 1 receptor antagonist | 0.024 0.016 DBMET01519 0.029 0.013 DBMET01520 | DBMET01520 | |
| 0.065 | 0.085 | 0.112 | Ornithine decarboxylase inhibitor | 0.112 0.032 DBMET01516 | DBMET01516 | |
| 0.106 | 0.127 | 0.124 | Vanilloid 1 agonist | 0.124 0.079 DBMET01516 | DBMET01516 | |
| 0.062 | 0.093 | 0.076 | Vanilloid 4 agonist | 0.076 0.048 DBMET01516 | DBMET01516 | |
| 0.029 | 0.06 | 0.041 | Histone deacetylase 9 inhibitor | 0.037 0.032 DBMET01516 0.041 0.024 DBMET01520 | DBMET01520 | |
| 0.145 | 0.178 | 0.175 | Streptokinase A inhibitor | 0.175 0.15 DBMET01516 | DBMET01516 | |
| 0.172 | 0.206 | 0.191 | Insulysin inhibitor | 0.191 0.171 DBMET01516 | DBMET01516 | |
| 0.024 | 0.059 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.023 DBMET01516 | DBMET01516 | |
| 0.011 | 0.057 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.012 DBMET01519 | DBMET01519 | |
| 0.05 | 0.096 | 0.067 | Histone deacetylase SIRT3 inhibitor | 0.067 0.033 DBMET01516 | DBMET01516 | |
| 0.033 | 0.081 | 0.076 | H+/K+-transporting ATPase inhibitor | 0.076 0.014 DBMET01519 0.063 0.022 DBMET01520 | DBMET01519 | |
| 0.047 | 0.098 | 0.104 | Benzodiazepine agonist | 0.104 0.023 DBMET01519 0.071 0.049 DBMET01520 | DBMET01519 | |
| 0.025 | 0.082 | 0.04 | Histamine H2 receptor agonist | 0.04 0.034 DBMET01516 | DBMET01516 | |
| 0.03 | 0.087 | 0.043 | Histamine H1 receptor agonist | 0.043 0.033 DBMET01516 | DBMET01516 | |
| 0.073 | 0.172 | 0.131 | Toll-Like receptor 9 antagonist | 0.124 0.082 DBMET01519 0.131 0.076 DBMET01520 | DBMET01520 | |
| 0.167 | 0.272 | 0.278 | Calcium channel activator | 0.278 0.115 DBMET01516 | DBMET01516 | |
| 0.016 | 0.13 | 0.087 | Neurokinin 2 antagonist | 0.087 0.012 DBMET01519 0.046 0.025 DBMET01520 | DBMET01519 | |
| 0.081 | 0.235 | 0.446 | Interleukin antagonist | 0.446 0.025 DBMET01519 0.428 0.027 DBMET01520 | DBMET01519 | |
| 0.105 | 0.266 | 0.165 | DNA damaging | 0.165 0.152 DBMET01519 | DBMET01519 | |
| 0.015 | 0.194 | 0.053 | Neurokinin antagonist | 0.053 0.03 DBMET01519 | DBMET01519 | |
| 0.131 | 0.315 | 0.666 | Toll-Like receptor 7 agonist | 0.666 0.011 DBMET01519 0.639 0.013 DBMET01520 | DBMET01519 | |
| 0.064 | 0.255 | 0.129 | Diuretic | 0.129 0.095 DBMET01519 0.127 0.097 DBMET01520 | DBMET01519 | |
| 0.127 | 0.321 | 0.661 | Toll-Like receptor agonist | 0.661 0.011 DBMET01519 0.634 0.014 DBMET01520 | DBMET01519 | |
| 0.192 | 0.397 | 0.276 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.276 0.247 DBMET01516 | DBMET01516 | |
| 0.103 | 0.311 | 0.178 | 5 Hydroxytryptamine release stimulant | 0.167 0.157 DBMET01516 0.178 0.143 DBMET01520 | DBMET01520 | |
| 0.058 | 0.27 | 0.136 | Histone deacetylase SIRT1 inhibitor | 0.136 0.075 DBMET01516 | DBMET01516 | |
| 0.054 | 0.265 | 0.525 | Interleukin 1 antagonist | 0.525 0.004 DBMET01519 0.433 0.005 DBMET01520 | DBMET01519 | |
| 0.009 | 0.425 | 0.176 | CC chemokine 5 receptor antagonist | 0.176 0.004 DBMET01519 0.163 0.004 DBMET01520 | DBMET01519 | |
| 0.007 | 0.512 | 0.145 | CXC chemokine receptor antagonist | 0.145 0.011 DBMET01519 0.109 0.021 DBMET01520 | DBMET01519 | |
| 0.022 | 0.647 | 0.449 | Interleukin 1b antagonist | 0.449 0.005 DBMET01519 0.398 0.005 DBMET01520 | DBMET01519 | |
| 0.025 | 0.708 | 0.11 | Toll-Like receptor 3 antagonist | 0.11 0.038 DBMET01516 0.097 0.056 DBMET01520 | DBMET01516 | |
| 0.018 | 0.712 | 0.546 | Tumour necrosis factor alpha release inhibitor | 0.546 0.01 DBMET01519 0.524 0.012 DBMET01520 | DBMET01519 | |
| 0.011 | 0.738 | 0.076 | Viral attachment inhibitor | 0.076 0.058 DBMET01519 | DBMET01519 | |
| 0.008 | 0.754 | 0.089 | Uric acid excretion stimulant | 0.089 0.066 DBMET01519 | DBMET01519 | |
| 0.061 | 0.868 | 0.441 | Calcium channel L-type activator | 0.441 0.056 DBMET01516 0.406 0.077 DBMET01520 | DBMET01516 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |